infectious disease

Malaria continues to drive urgent research worldwide, with new therapies and tools emerging to combat the parasite’s complex lifecycle and global burden.

A compound that inhibits replication of the dengue virus in mammals was similarly effective in mosquitoes consuming it via blood, reducing transmissibility. 

Merck researchers developed an effective vaccine against pneumococcal diseases.

Organic molecules with novel biological properties offer new ways to eliminate multidrug-resistant bacteria. 

New research aims to make antibody drug delivery as precise and efficient as the antibodies themselves.

Scientists weaponize the symbiotic bacteria in mosquitoes against the deadly diseases they transmit.

Pioneering approaches transform vaccine technologies and shape the future of disease prevention.

Epithelial cells partner with tissue-resident memory cells to protect the lung during Streptococcus pneumoniae infection.

With a star-shaped drug delivery platform that can stay in the stomach for a week or more, researchers hope to improve medication compliance and overall health.

Researchers investigate new approaches to revolutionizing vaccines for cancer and infectious diseases.